Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 07-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -9,178 | N/A | N/A |
| Depreciation Amortization | 425 | N/A | N/A |
| Accounts payable and accrued liabilities | -15 | N/A | N/A |
| Other Working Capital | 365 | N/A | N/A |
| Other Operating Activity | 7,655 | 0 | 0 |
| Operating Cash Flow | $-747 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 350 | N/A | N/A |
| Common Stock Issued | 55 | N/A | N/A |
| Other Financing Activity | 921 | 0 | 0 |
| Financing Cash Flow | $1,326 | $N/A | $N/A |
| Beginning Cash Position | 20 | N/A | N/A |
| End Cash Position | 599 | N/A | N/A |
| Net Cash Flow | $578 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -747 | N/A | N/A |
| Free Cash Flow | -747 | 0 | 0 |